Pacira BioSciences, Inc.

By person

36 insiders · 361 transactions

17.1×

Frank Lee holds 17.1 times base salary in stock. $15.35M of shares against $896.54K in salary for 2024.

Salary from the company's own proxy. The shares are what Frank Lee last reported holding, valued at $23.23, the price Common Stock was last bought or sold at on the open market here, on 17 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Wicki Andreas

Director

—

$40.51M (20)

−$40.51M

2,393,165

6.00%

$55.59M

−21.3%

STACK DAVID M

CEO and Chairman

—

$31.79M (56) scheduled

−$31.79M

302,980

0.7601%

$7.04M

+437.6%

WILLIAMS KRISTEN

Chief Administrative Officer

—

$14.18M (41) scheduled

−$14.18M

167,062

0.4191%

$3.88M

+967.5%

REINHARDT MAX

President, Rest of World

—

$6.61M (17) scheduled

−$6.61M

29,225

0.0733%

$678.90K

+2,050%

PACE GARY W

Director

$412.97K (2)

$5.87M (6)

−$5.46M

22,127

0.0555%

$514.01K

−0.2%

RIKER LAUREN

Senior Vice President, Finance

—

$4.73M (48) scheduled

−$4.73M

62,284

0.1563%

$1.45M

+346.3%

LARANJEIRA CHARLES ANTHONY

Chief Technical Officer

—

$3.81M (12) scheduled

−$3.81M

41,752

0.1047%

$969.90K

+1,667%

WINSTON ROY

Chief Medical Officer

$91.25K (1)

$3.31M (19) scheduled

−$3.22M

52,440

0.1316%

$1.22M

+163.8%

Scibetta James S

President

—

$2.61M (5) scheduled

−$2.61M

25,118

0.0630%

$583.49K

−7.3%

MOLLOY ANTHONY

Chief Lgl & Compliance Officer

—

$2.36M (11) scheduled

−$2.36M

12,877

0.0323%

$299.13K

−20.5%

Scranton Richard

Chief Scientific Officer

—

$1.98M (6) scheduled

−$1.98M

16,061

0.0403%

$373.10K

+231.6%

Cross Shawn

Chief Financial Officer

—

$1.52M (7) scheduled

−$1.52M

105,341

0.2643%

$2.45M

—

Brege Laura

Director

$12.81K (1)

$1.20M (4) scheduled

−$1.19M

30,120

0.0756%

$699.69K

+1,111%

LONGENECKER JOHN P PHD

Director

—

$923.42K (3) scheduled

−$923.42K

18,823

0.0472%

$437.26K

+396.9%

HASTINGS PAUL J

Director

—

$800.68K (10) scheduled

−$800.68K

12,724

0.0319%

$295.58K

+297.0%

SLONIN JONATHAN

Chief Medical Officer

—

$628.00K (12) scheduled

−$628.00K

216,384

0.5428%

$5.03M

+537.0%

McLoughlin Dennis

Chief Customer Officer

—

$608.87K (7)

−$608.87K

38,115

0.0956%

$885.41K

+125.7%

Reinhart Charles A. III

Chief Financial Officer

—

$555.97K (7)

−$555.97K

51,867

0.1301%

$1.20M

—

Kronenfeld Mark A.

Director

$152.46K (4)

$555.60K (1) scheduled

−$403.14K

34,901

0.0876%

$810.75K

+686.4%

GAUGLER DARYL

Chief Operating Officer

—

$327.84K (8) scheduled

−$327.84K

115,443

0.2896%

$2.68M

+784.5%

Manning Donald C.

Chief Medical Officer

—

$306.82K (2)

−$306.82K

29,520

0.0741%

$685.75K

—

Froimson Mark

Director

$19.93K (2)

$123.31K (3)

−$103.39K

26,541

0.0666%

$616.55K

—

Lee Frank D.

Chief Executive Officer

$99.99K (1)

—

+$99.99K

660,831

1.66%

$15.35M

+48,354%

Ellis Ronald J. Jr.

Chief Strategy Officer

—

$87.44K (2)

−$87.44K

30,909

0.0775%

$718.02K

−6.9%

Jones James B

SVP & Chief Medical Officer

—

$68.17K (2)

−$68.17K

16,823

0.0422%

$390.80K

+53.8%

Ceesay Abraham

Director

—

$64.01K (1) scheduled

−$64.01K

9,039

0.0227%

$209.98K

—

BIGAL MARCELO

Director

$60.87K (2)

$116.27K (1)

−$55.40K

17,798

0.0446%

$413.45K

—

Braunstein Scott

Chief Operating Officer

—

$33.27K (1)

−$33.27K

20,982

0.0526%

$487.41K

+95.2%

YANG MICHAEL J.

Director

$25.80K (1)

—

+$25.80K

19,798

0.0497%

$459.91K

—

Weiland Robert J.

Chief Commercial Officer

—

$12.32K (1)

−$12.32K

5,088

0.0128%

$118.19K

+429.4%

Teehan Brendan

Chief Commercial Officer

—

100,934

0.2532%

$2.34M

—

CHRISTIE CHRISTOPHER

Director

—

23,059

0.0578%

$535.66K

—

Young Alethia

Director

—

17,798

0.0446%

$413.45K

—

Greenstreet Yvonne

Director

—

13,247

0.0332%

$307.73K

+279.8%

WINGER DENNIS L

Director

—

7,490

0.0188%

$173.99K

+22.1%

Hirawat Samit

Director

—

6,405

0.0161%

$148.79K

—

Pacira BioSciences, Inc.

By person

Individual transactions

What was left out